Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Merck
Teva
Argus Health
Farmers Insurance
Medtronic
McKesson
Cipla
Accenture

Generated: May 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,385,048

« Back to Dashboard

Summary for Patent: 4,385,048
Title: Methods for the treatment of nasal hypersecretion
Abstract:Compositions for the treatment of nasal hypersecretion comprising (8r)-8-isopropyl-3.alpha.-[(.+-.)-tropoyl-oxy]-1.alpha.H, 5.alpha.H-tropanium bromide in a pharmaceutical formulation suitable for topical application to the nasal cavity; and methods of use.
Inventor(s): Mygind; Niels (Birkeroed, DK), Borum; Peter (Soeborg, DK), Grieben; Christiane (Ingelheim am Rhein, DE)
Assignee: Boehringer Ingelheim GmbH (Ingelheim am Rhein, DE)
Application Number:06/208,411
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form; Formulation;

Drugs Protected by US Patent 4,385,048

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,385,048

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany2903957Feb 02, 1979

International Family Members for US Patent 4,385,048

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Germany 2903957 ➤ Try a Free Trial
Australia 4865079 ➤ Try a Free Trial
Australia 530174 ➤ Try a Free Trial
New Zealand 190897 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Fish and Richardson
Covington
Julphar
Cerilliant
UBS
Federal Trade Commission
Chubb
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.